New setback for Trump: banning hydroxychloroquine against coronavirus

The agency Food and Drug Administration of the United States (FDA) in charge of enabling the sale and massive consumption of medicines, concluded that the hydroxychloroquine and chloroquine drugs are not effective in the treatment of the coronavirus and revoked the authorization for its use, despite the fact that the President himself said that he was consuming it just a few weeks ago.

"In view of the serious heart accidents and other serious side effects, the known benefits and The potentials of chloroquine and hydroxychloroquine do not outweigh the known and potential risks of their authorized use, "the FDA reported in a statement.

Specifically, the FDA cites the results of a clinical study in patients who they have Covid-19 and are hospitalized. The results "demonstrate that hydroxychloroquine has had no positive effect on mortality or accelerated recovery," the federal agency said, according to the DPA news agency.

"We have made it clear throughout from this public health emergency that our actions would be guided by science and that our decisions could evolve as we learned more about the SARS-CoV-2 virus, " technical name of the new coronavirus, explained the Deputy Commissioner for Medical Affairs and FDA Scientists, Anand Shah.

The FDA issued an authorization for the emergency use of chloroquine and hydroxychloroquine last March, at the start of the pandemic, for patients hospitalized for coronaviruses and those who participate in clinical trials.

As early as April, the agency had publicly requested that these drugs not be prescribed outside of medical facilities, something that did not prevent Trump from announcing The following month, I was using hydroxychloroquine, only as a preventive measure.

These two drugs have been used for decades to treat malaria and are also often prescribed for lupus and rheumatoid arthritis, so doctors will still be able to administer it to coronavirus patients, as long as they are not specifically prescribed for Covid-19.

The decision made by the FDA does not signify the end of clinical trials with these two drugs for Covid-19 sufferers, only use outside of these controlled trials.

Trump, during March and April, advocated the use of hydroxychloroquine as a treatment against coronavirus. He maintained that patients "have nothing to lose" taking this medicine and even suggested its use as a preventive measure.

Despite the criticism that this generated, in mid-May, the president announced to the press that he was taking the drug preventively and which had no side effects.

The use and effectiveness of hydroxychloroquine has been one of the most controversial issues in the world during this pandemic.

The World Health Organization ( WHO) went on to suspend its clinical trials, but later resumed them because, it recognized, it had been based on dubious evidence that had been reproduced by respected scientific journals, which further fueled global controversy.

Today, the only consensus What exists on the subject is that there is no serious international evidence that either drug has positive effects on Covid-19 patients, justifying the risk of potential side effects. [19659016]
Source link